Hützler Wilhelm Maximilian, Egert Ernst, Bolte Michael
Institut für Organische Chemie und Chemische Biologie, Goethe-Universität Frankfurt, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany.
Institut für Anorganische und Analytische Chemie, Goethe-Universität Frankfurt, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany.
Acta Crystallogr C Struct Chem. 2016 Sep 1;72(Pt 9):705-15. doi: 10.1107/S205322961601336X. Epub 2016 Aug 26.
A path to new synthons for application in crystal engineering is the replacement of a strong hydrogen-bond acceptor, like a C=O group, with a weaker acceptor, like a C=S group, in doubly or triply hydrogen-bonded synthons. For instance, if the C=O group at the 2-position of barbituric acid is changed into a C=S group, 2-thiobarbituric acid is obtained. Each of the compounds comprises two ADA hydrogen-bonding sites (D = donor and A = acceptor). We report the results of cocrystallization experiments of barbituric acid and 2-thiobarbituric acid, respectively, with 2,4-diaminopyrimidine, which contains a complementary DAD hydrogen-bonding site and is therefore capable of forming an ADA/DAD synthon with barbituric acid and 2-thiobarbituric acid. In addition, pure 2,4-diaminopyrimidine was crystallized in order to study its preferred hydrogen-bonding motifs. The experiments yielded one ansolvate of 2,4-diaminopyrimidine (pyrimidine-2,4-diamine, DAPY), C4H6N4, (I), three solvates of DAPY, namely 2,4-diaminopyrimidine-1,4-dioxane (2/1), 2C4H6N4·C4H8O2, (II), 2,4-diaminopyrimidine-N,N-dimethylacetamide (1/1), C4H6N4·C4H9NO, (III), and 2,4-diaminopyrimidine-1-methylpyrrolidin-2-one (1/1), C4H6N4·C5H9NO, (IV), one salt of barbituric acid, viz. 2,4-diaminopyrimidinium barbiturate (barbiturate is 2,4,6-trioxopyrimidin-5-ide), C4H7N4(+)·C4H3N2O3(-), (V), and two solvated salts of 2-thiobarbituric acid, viz. 2,4-diaminopyrimidinium 2-thiobarbiturate-N,N-dimethylformamide (1/2) (2-thiobarbiturate is 4,6-dioxo-2-sulfanylidenepyrimidin-5-ide), C4H7N4(+)·C4H3N2O2S(-)·2C3H7NO, (VI), and 2,4-diaminopyrimidinium 2-thiobarbiturate-N,N-dimethylacetamide (1/2), C4H7N4(+)·C4H3N2O2S(-)·2C4H9NO, (VII). The ADA/DAD synthon was succesfully formed in the salt of barbituric acid, i.e. (V), as well as in the salts of 2-thiobarbituric acid, i.e. (VI) and (VII). In the crystal structures of 2,4-diaminopyrimidine, i.e. (I)-(IV), R2(2)(8) N-H...N hydrogen-bond motifs are preferred and, in two structures, additional R3(2)(8) patterns were observed.
在晶体工程中应用新合成子的一条途径是,在双氢键或三氢键合成子中,用较弱的氢键受体(如C=S基团)取代较强的氢键受体(如C=O基团)。例如,如果将巴比妥酸2位的C=O基团换成C=S基团,就会得到2-硫代巴比妥酸。每种化合物都包含两个ADA氢键位点(D = 供体,A = 受体)。我们分别报道了巴比妥酸和2-硫代巴比妥酸与2,4-二氨基嘧啶的共结晶实验结果,2,4-二氨基嘧啶含有互补的DAD氢键位点,因此能够与巴比妥酸和2-硫代巴比妥酸形成ADA/DAD合成子。此外,使纯的2,4-二氨基嘧啶结晶,以研究其优选的氢键模式。实验得到了一种2,4-二氨基嘧啶的无水物(嘧啶-2,4-二胺,DAPY),C4H6N4,(I),三种DAPY的溶剂化物,即2,4-二氨基嘧啶-1,4-二氧六环(2/1),2C4H6N4·C4H8O2,(II),2,4-二氨基嘧啶-N,N-二甲基乙酰胺(1/1),C4H6N4·C4H9NO,(III),以及2,4-二氨基嘧啶-1-甲基吡咯烷-2-酮(1/1),C4H6N4·C5H9NO,(IV),一种巴比妥酸的盐,即2,4-二氨基嘧啶鎓巴比妥酸盐(巴比妥酸盐为2,4,6-三氧代嘧啶-5-负离子),C4H7N4(+)·C4H3N2O3(-),(V),以及两种2-硫代巴比妥酸的溶剂化盐,即2,4-二氨基嘧啶鎓2-硫代巴比妥酸盐-N,N-二甲基甲酰胺(1/2)(2-硫代巴比妥酸盐为4,6-二氧代-2-硫亚基嘧啶-5-负离子),C4H7N4(+)·C